Furthermore, since high doses of NLGN3 are toxic to GBM cells under three-dimensional culture conditions and the efficacy of recombinant NLGN3 affect each cell differently (A172, LN229, and U87MG cells), it suggests that other effective factors may exist depending on the tumor environment; this requires further investigation. This evidence concerns the gene NLGN3 and glioblastoma.